Evidence map›Paper›PMID 19187763›Full record

ArticleMolecular cell2009

An unexpected type of ribosomes induced by kasugamycin: a look into ancestral times of protein synthesis?

Anna Chao Kaberdina, Witold Szaflarski, Knud H Nierhaus, Isabella Moll

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. In vivo structure probing of RNA inRNA (New York, N.Y.) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Dissipation and dietary risk assessment of kasugamycin and saisentong in Chinese cabbage.Environmental science and pollution research international · 2020
    Article
  16. Review
  17. Selective translation by alternative bacterial ribosomes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Article
  20. Synonymous Mutations inFrontiers in microbiology · 2020
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Anna Chao KaberdinaMax F. Perutz Laboratories, Department of Microbiology and Immunobiology, University Departments at the Vienna Biocenter, Vienna, Austria.
Witold Szaflarski
Knud H Nierhaus
Isabella Moll
Max Perutz Labs · ATMax Planck Society · DE

Funding

Austrian Science Fund FWF P 20112Austrian Science Fund FWF T 259
6 · The paper itself

Abstract

Translation of leaderless mRNAs, lacking ribosomal recruitment signals other than the 5'-terminal AUG-initiating codon, occurs in all three domains of life. Contemporary leaderless mRNAs may therefore be viewed as molecular fossils resembling ancestral mRNAs. Here, we analyzed the phenomenon of sustained translation of a leaderless mRNA in the presence of the antibiotic kasugamycin. Unexpected from the known in vitro effects of the drug, kasugamycin induced the formation of stable approximately 61S ribosomes in vivo, which were proficient in selectively translating leaderless mRNA. 61S particles are devoid of more than six proteins of the small subunit, including the functionally important proteins S1 and S12. The lack of these proteins could be reconciled with structural changes in the 16S rRNA. These studies provide in vivo evidence for the functionality of ribosomes devoid of multiple proteins and shed light on the evolutionary history of ribosomes.

Indexed as

AminoglycosidesAnti-Bacterial AgentsEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialModels, BiologicalModels, MolecularNucleic Acid ConformationPeptide Chain Initiation, TranslationalProtein BiosynthesisProtein ConformationRibosomesRNA, BacterialRNA, Ribosomal, 16SAminoglycosidesAnti-Bacterial AgentsEscherichia coli ProteinskasugamycinRNA, BacterialRNA, Ribosomal, 16S

Identifiers

PMID19187763
PMCPMC2967816
OpenAlexW1985737105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.